A mouse oral alveolar lavage needle

By designing a transoral alveolar lavage needle for mice, using a spherical blunt part and a conical structure for the cannula body, combined with mechanical restraint of the handpiece, the problems of complex operation, unreliable fixation and high cost of alveolar lavage in mice are solved, achieving efficient, safe and reusable alveolar lavage.

CN224975033UActive Publication Date: 2026-11-17GUANGZHOU MEDICAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202522143929.6
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-10-10
Publication Date
2026-11-17
Estimated Expiration
2035-10-10

AI Technical Summary

Technical Problem

Existing technologies for mouse alveolar lavage are cumbersome, have unreliable fixation methods that are prone to slippage, pose a high risk of puncture and injury, are costly, and cannot be reused, making it difficult to meet high sterility requirements.

Method used

A transoral bronchoalveolar lavage needle for mice is designed, featuring a spherical blunt part and a conical structure for the cannula body, combined with mechanical restraint at the handpiece. Made of PP material and polyacrylic acid resin, it has high pressure resistance and is suitable for high temperature and high pressure sterilization, ensuring smooth and stable cannulation.

Benefits of technology

Simplify the operation process, improve intubation efficiency, reduce experimental time and costs, ensure that the lavage fluid is free of blood contamination, improve detection accuracy, reduce the risk of failure, achieve reusability and sterility, and improve the recovery rate of bronchoalveolar lavage fluid and the reliability of test results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224975033U_ABST
    Figure CN224975033U_ABST
Patent Text Reader

Abstract

This invention discloses a transoral alveolar lavage needle for mice, comprising a hollow cannula body, a blunt portion (spherical blunt portion) at the tail end for guiding insertion into the mouse trachea, and a handle at the head end for engaging with the mouse's oral cavity. The handle has a connector that connects to the hollow structure. Both the cannula body and the hollow structure have conical structures. This invention uses the handle for insertion control, combined with the spherical blunt portion, to insert the cannula into the mouse trachea via the oral cavity. This minimizes the risk of scratching the oral cavity and airway during insertion, achieving a non-invasive, rapid, and stable transoral alveolar lavage procedure. It completely eliminates the cumbersome steps of tracheostomy and ligation required in traditional methods, significantly improving operational efficiency, success rate, and sample quality.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the technical field of experimental bronchoalveolar lavage needles, specifically to an oral bronchoalveolar lavage needle for mice. Background Technology

[0002] In the field of biomedical research, mice are commonly used laboratory animals. They often need to obtain bronchoalveolar lavage fluid through bronchoalveolar lavage for subsequent biological testing. The quality of the bronchoalveolar lavage fluid obtained by bronchoalveolar lavage is crucial to the accuracy of the test. Bronchoalveolar lavage is mainly performed with precision through a cannulation lavage device, and the performance of the cannulation device directly affects the accuracy of the experimental results. Currently, there are no dedicated oral alveolar lavage needles for mice on the market. Related experimental procedures must rely on alternative methods. Existing methods mainly involve using 22G or 24G intravenous catheters. Both 22G and 24G catheters consist of a cannula and a cored needle. This involves inserting the catheter after making a small incision in the tracheal wall, removing the cored needle, and then securing the trachea to the cannula with fine thread for subsequent lavage. This procedure has the following problems: 1. It requires meticulous dissection, and the process of fully exposing the trachea and making the incision is cumbersome and time-consuming, significantly reducing experimental efficiency; 2. Due to the dense blood vessels and rich blood supply in the mouse neck, blood vessels are easily severed during dissection, causing blood to mix with the alveolar lavage fluid through the tracheostomy, directly interfering with protein detection, cell counting, and cytokine detection results; 3. The stability of the fine thread binding method is extremely poor. During the experiment, the cannula is prone to slippage. If it slips out and shifts into the lung lobe or bronchioles, it will cause deviation in the lavage area. If it completely detaches from the trachea, it will directly lead to experimental failure. Even if the initial insertion depth is fixed with a thin thread, the subsequent repeated aspiration of lavage fluid will still generate axial thrust: on the one hand, it may push the cannula to continue to move downwards and penetrate deeper into the lung lobe, damaging lung tissue and limiting the lavage area; on the other hand, when removing the syringe to replace consumables, the friction between the syringe and the cannula may pull the cannula out of the trachea, requiring the cannula to be fixed to the trachea with a thin thread again, prolonging the experimental time and further increasing the risk of experimental failure. 4. The traditional use of 22G or 24G intravenous indwelling needles is not only expensive, but also can only be reused to a limited extent after cleaning. Due to the limitations of their material, the indwelling needles cannot be autoclaved, so their application is limited in experiments requiring high sterility conditions (such as pathogen analysis), and it is difficult to meet the strict requirements of aseptic operation procedures. Utility Model Content

[0003] This utility model addresses the shortcomings of existing technologies by providing a transoral alveolar lavage needle for mice. It aims to solve the technical problems of existing endotracheal intubation methods using 22G or 24G intravenous indwelling needles, such as cumbersome operation steps, unreliable fixation methods that are prone to slippage, risks of puncture and injury during use, and high experimental costs due to the inability to reuse the instruments.

[0004] The technical solution adopted by this utility model to achieve the above objectives is as follows: A transoral bronchoalveolar lavage needle for mice includes a cannula body with a hollow structure. The tail end of the cannula body has a blunt portion for guiding the cannula body into the trachea of ​​a mouse, and the head end of the cannula body has a handle for locking in the mouth of a mouse. The handle has a connector, which is connected to the hollow structure. Both the cannula body and the hollow structure have a conical structure.

[0005] As a further improvement, the blunt portion is a spherical blunt portion, and the diameter of the spherical blunt portion is less than 1.23 mm.

[0006] As a further improvement, the hollow structure is provided with a first opening at its tail end, the diameter of which is 0.32 mm. As a further improvement, the hollow structure is provided with a second opening at its head end, the diameter of which is 2.55mm.

[0007] As a further improvement, the length of the cannula body is 25mm.

[0008] As a further improvement, the angle at which the cannula body tilts from the head end to the tail end and the angle at which the hollow structure tilts from the head end to the tail end are both 2°.

[0009] As a further improvement, the width of the handheld part is 28mm.

[0010] As a further improvement, the connector is a Luer connector.

[0011] As a further improvement, the blunt portion is made of polyacrylic resin.

[0012] As a further improvement, the cannula body is made of PP material.

[0013] Compared with the prior art, the above-mentioned technical solutions of the oral bronchoalveolar lavage needle for mice provided in this embodiment of the present invention have at least one of the following technical effects: 1. This invention achieves precise intubation by incorporating a handheld part and a spherical blunt part for guidance, allowing the intubation tube to be smoothly inserted into the mouse trachea through the mouth. This invention simplifies and speeds up intubation, requiring only simple exposure of the trachea and direct visualization to confirm the spherical blunt part is within the lumen. It completely eliminates the complex steps of tracheostomy, intubation, and ligation in traditional methods, significantly improving operational efficiency and greatly reducing experimental time costs.

[0014] 2. The ball-shaped blunt end provides soft support, preventing scratches to the oral cavity and airway during insertion. Combined with the cone-shaped cannula body, it forms a double-protection structure to prevent damage. It is adapted to the gradually narrowing trachea of ​​mice, without compression damage, and there is no sharp contact throughout the process, completely avoiding vascular rupture and bleeding, ensuring that the bronchoalveolar lavage fluid is free of blood contamination, and guaranteeing the accuracy of results such as protein detection, cell counting, and cytokine detection.

[0015] 3. By setting up a handhold, the cannula body can be stably locked in the mouse's mouth, forming a mechanical limit, replacing the binding with thin thread. This not only prevents the cannula body from shifting downwards during repeated aspiration, but also avoids the cannula body being pulled out when the syringe is removed, improving the safety of use, reducing the risk of experimental failure, and increasing the success rate of the experiment.

[0016] 4. This utility model uses PP material to make the cannula body and polyacrylic acid resin to make the whole body have high pressure resistance. After high temperature and high pressure sterilization, the mouse oral alveolar lavage needle is structurally stable and does not deform, and can be reused. At the same time, it achieves a sterile state after sterilization, taking into account cost control and experimental sterility requirements, and reducing costs.

[0017] 5. This invention can significantly improve the recovery rate of bronchoalveolar lavage fluid, reaching approximately 90%. Compared with the traditional endotracheal intubation method, the operation time can be shortened by about half, thereby greatly improving the success rate of bronchoalveolar lavage and obtaining higher quality bronchoalveolar lavage fluid, thus improving the accuracy and reliability of subsequent test results. Attached Figure Description

[0018] To more clearly illustrate the technical solutions in the embodiments of this utility model, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this utility model. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0019] Figure 1 This is a schematic diagram of the overall structure of the oral bronchoalveolar lavage needle for mice in this embodiment; Figure 2 This is a bottom view of the oral alveolar lavage needle used in mice according to this embodiment; Figure 3 for Figure 2 AA section view diagram; Figure 4 for Figure 3 An enlarged diagram of A in the diagram. Detailed Implementation

[0020] The following description is only a preferred embodiment of the present invention and does not limit the scope of protection of the present invention.

[0021] For examples, see the appendix. Figures 1-4 A transoral bronchoalveolar lavage needle 1 for mice includes a cannula body 3 with a hollow structure 2. The cannula body 3 is integrally injection molded. The tail end of the cannula body 3 has a blunt part 4 for guiding the cannula body 3 into the trachea of ​​a mouse. The head end of the cannula body 3 has a handle 5 for locking in the mouth of a mouse. The handle 5 has a connector 6, which is connected to the hollow structure 2. Both the cannula body 3 and the hollow structure 2 have a conical structure 7. The blunt part 4 is made of polyacrylic acid resin, and the cannula body 3 is made of PP material. The use of polyacrylic acid resin for the blunt part 4 and PP material for the cannula body 3 improves the high pressure resistance of the transoral bronchoalveolar lavage needle 1 for mice. After cleaning and high pressure sterilization, it can be reused, improving the reusability rate. It can withstand high pressure sterilization at 121℃, 0.1MPa, and 30min. After sterilization, the structure is stable and does not deform, allowing for reuse and reducing costs. The diameter of the tail end of the cannula body 3 is 0.8mm.

[0022] The blunt portion 4 is a spherical blunt portion with a diameter of less than 1.23 mm. The spherical blunt portion is formed by a drip-molding process. The spherical blunt portion is used to provide guidance and support, thereby ensuring the smooth insertion of the intubation tube body 3 into the mouse trachea and minimizing damage to the oral cavity and airway, thus improving the safety of use. During insertion, the blunt portion 4 enters the trachea from the oral cavity. Due to the arc-shaped outer surface of the spherical blunt portion, the intubation tube body 3 is guided into the trachea. Continued pushing allows the intubation tube body 3 to be fully inserted into the trachea, completing the intubation action.

[0023] The hollow structure 2 has a first opening 20 at its tail end, with a diameter of 0.32 mm. The hollow structure 2 also has a second opening 21 at its head end, with a diameter of 2.55 mm. The diameter of the second opening 21 gradually decreases towards the first opening 20, forming a conical structure 7. The hollow structure 2 of the conical structure 7 serves as a guide, thereby improving the smoothness of insertion of the auxiliary device and enhancing operational convenience. The inclination angle of the cannula body 3 from head to tail and the inclination angle of the hollow structure 2 from head to tail are both 2°. The conical structure 7 of the cannula body 3 serves to gradually expand and guide, making it less likely to damage the mouse's mouth and airway when inserted into the trachea through the mouse's mouth. This reduces the risk of blood mixing into the bronchoalveolar lavage fluid due to scratches or causing tracheal perforation that prevents lavage, thus ensuring subsequent test results.

[0024] The length of the cannula body 3 is 25mm, the width of the handle part 5 is 28mm, the thickness of the handle part 5 is preferably 1mm, the connector 6 is a Luer connector, the connector 6 is provided with a first channel 60, the diameter of the first channel 60 is larger than the diameter of the second opening 21, the first channel 60 is preferably a frustum structure, the handle part 5 is used to provide a limiting and locking function, thereby stably locking the cannula body 3 in the mouse's oral cavity and ensuring the irrigation depth, avoiding the situation where the cannula body 3 is inserted too deeply into the mouse's lung lobe or inserted too shallowly, resulting in insufficient subsequent irrigation, thereby improving the accuracy of subsequent test results.

[0025] This invention features a handheld part for precise intubation and a spherical blunt end for guidance, allowing the intubation tube to be smoothly inserted into the mouse trachea through the mouth. This invention simplifies and speeds up intubation, requiring only simple exposure of the trachea and direct visualization to confirm the spherical blunt end is within the lumen. It completely eliminates the complex steps of tracheostomy, intubation, and ligation required in traditional methods, significantly improving operational efficiency and greatly reducing experimental time costs. The spherical blunt end provides soft support, minimizing the risk of scratching the mouth and airway during insertion. Combined with the conical structure of the intubation tube, it forms a double-layered damage prevention structure, adapting to the gradually narrowing trachea of ​​mice, preventing compression damage, and eliminating sharp contact throughout the procedure. This completely avoids vascular rupture and bleeding, ensuring the bronchoalveolar lavage fluid is free of blood contamination and guaranteeing the accuracy of protein detection, cell counting, and cytokine detection results. The design incorporates a handheld part that allows the cannula to be stably secured in the mouse's mouth, creating a mechanical restraint and replacing the need for string binding. This prevents the cannula from shifting downwards during repeated aspiration and avoids it being pulled out when the syringe is removed, improving safety, reducing the risk of experimental failure, and increasing the success rate. The cannula body is made of PP material, and the blunt part is made of polyacrylic acid resin to ensure high-pressure resistance. After high-temperature and high-pressure sterilization, the mouse oral alveolar lavage needle remains structurally stable and undeformed, allowing for reusability. Sterilization achieves a sterile state, balancing cost control with experimental aseptic requirements, thus reducing costs. This invention significantly improves the recovery rate of alveolar lavage fluid, reaching approximately 90%. Compared to traditional endotracheal intubation methods, the operation time can be reduced by about half, greatly improving the success rate of alveolar lavage and obtaining higher-quality alveolar lavage fluid, thereby enhancing the accuracy and reliability of subsequent test results.

[0026] This utility model is not limited to the above-described embodiments. Other oral alveolar lavage needles for mice that use the same or similar structures or devices as those described in the above embodiments are all within the protection scope of this utility model.

Claims

1. A mouse oral bronchioalveolar lavage needle, characterized by: The device includes a hollow tube body, the tail end of which has a blunt portion for guiding the tube body into the trachea of ​​a mouse, and the head end of which has a handle for locking into the mouth of a mouse. The handle has a connector that is connected to the hollow structure. Both the tube body and the hollow structure have a conical structure.

2. The mouse oral bronchioalveolar lavage needle according to claim 1, wherein: The blunt portion is a spherical blunt portion, and the diameter of the spherical blunt portion is less than 1.23 mm.

3. The mouse oral bronchioalveolar lavage needle according to claim 2, wherein: The hollow structure has a first opening at its tail end, and the diameter of the first opening is 0.32 mm.

4. The oral alveolar lavage needle for mice according to claim 1, characterized in that: The hollow structure has a second opening at its head end, and the diameter of the second opening is 2.55 mm.

5. The oral alveolar lavage needle for mice according to claim 1, characterized in that: The length of the cannula body is 25mm.

6. The oral alveolar lavage needle for mice according to claim 1, characterized in that: The angle at which the cannula body tilts from the head end to the tail end and the angle at which the hollow structure tilts from the head end to the tail end are both 2°.

7. The oral alveolar lavage needle for mice according to claim 1, characterized in that: The width of the handheld part is 28mm.

8. The oral alveolar lavage needle for mice according to claim 1, characterized in that: The connector is a Luer connector.

9. The oral alveolar lavage needle for mice according to claim 2, characterized in that: The blunt portion is made of polyacrylic resin.

10. The oral alveolar lavage needle for mice according to claim 1, characterized in that: The cannula body is made of PP material.